40 related articles for article (PubMed ID: 35107852)
1. miR-152 is involved in the proliferation and metastasis of ovarian cancer through repression of ERBB3.
Li LW; Xiao HQ; Ma R; Yang M; Li W; Lou G
Int J Mol Med; 2018 Mar; 41(3):1529-1535. PubMed ID: 29286064
[TBL] [Abstract][Full Text] [Related]
2. Methylation-mediated repression of MiR-424/503 cluster promotes proliferation and migration of ovarian cancer cells through targeting the hub gene KIF23.
Li T; Li Y; Gan Y; Tian R; Wu Q; Shu G; Yin G
Cell Cycle; 2019 Jul; 18(14):1601-1618. PubMed ID: 31135262
[TBL] [Abstract][Full Text] [Related]
3. PFKFB3-mediated glycolysis in hepatic stellate cells promotes liver regeneration.
Cao Y; Wang S; Zhang M; Lai B; Liang Y
Biochem Biophys Res Commun; 2024 Jun; 712-713():149958. PubMed ID: 38640731
[TBL] [Abstract][Full Text] [Related]
4. Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.
Shah NR; Tancioni I; Ward KK; Lawson C; Chen XL; Jean C; Sulzmaier FJ; Uryu S; Miller NL; Connolly DC; Schlaepfer DD
Gynecol Oncol; 2014 Jul; 134(1):104-11. PubMed ID: 24786638
[TBL] [Abstract][Full Text] [Related]
5. Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination.
Gustafsson NMS; Färnegårdh K; Bonagas N; Ninou AH; Groth P; Wiita E; Jönsson M; Hallberg K; Lehto J; Pennisi R; Martinsson J; Norström C; Hollers J; Schultz J; Andersson M; Markova N; Marttila P; Kim B; Norin M; Olin T; Helleday T
Nat Commun; 2018 Sep; 9(1):3872. PubMed ID: 30250201
[TBL] [Abstract][Full Text] [Related]
6. Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo.
De Oliveira T; Goldhardt T; Edelmann M; Rogge T; Rauch K; Kyuchukov ND; Menck K; Bleckmann A; Kalucka J; Khan S; Gaedcke J; Haubrock M; Beissbarth T; Bohnenberger H; Planque M; Fendt SM; Ackermann L; Ghadimi M; Conradi LC
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33671096
[TBL] [Abstract][Full Text] [Related]
7. A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models.
Xintaropoulou C; Ward C; Wise A; Marston H; Turnbull A; Langdon SP
Oncotarget; 2015 Sep; 6(28):25677-95. PubMed ID: 26259240
[TBL] [Abstract][Full Text] [Related]
8. Down-Regulation of CPEB4 Alleviates Preeclampsia through the Inhibition of Ferroptosis by PFKFB3.
Song J; Yang H
Crit Rev Eukaryot Gene Expr; 2024; 34(3):73-82. PubMed ID: 38305290
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-26b suppresses autophagy in breast cancer cells by targeting DRAM1 mRNA, and is downregulated by irradiation.
Meng C; Liu Y; Shen Y; Liu S; Wang Z; Ye Q; Liu H; Liu X; Jia L
Oncol Lett; 2018 Feb; 15(2):1435-1440. PubMed ID: 29399189
[TBL] [Abstract][Full Text] [Related]
10. Metabolic regulation of calcium pumps in pancreatic cancer: role of phosphofructokinase-fructose-bisphosphatase-3 (PFKFB3).
Richardson DA; Sritangos P; James AD; Sultan A; Bruce JIE
Cancer Metab; 2020; 8():2. PubMed ID: 32266066
[TBL] [Abstract][Full Text] [Related]
11. Commentary: PFKFB3 overexpression in monocytes of patients with colon but not rectal cancer programs pro-tumor macrophages and is indicative for higher risk of tumor relapse.
Shakhpazyan N; Mikhaleva L; Bedzhanyan A; Sadykhov N; Midiber K; Orekhov A
Front Immunol; 2023; 14():1290459. PubMed ID: 38193086
[No Abstract] [Full Text] [Related]
12. Retraction Note: MiRNA-26b inhibits the proliferation, migration, and epithelial-mesenchymal transition of lens epithelial cells.
Dong N; Xu B; Benya SR; Tang X
Mol Cell Biochem; 2024 Apr; ():. PubMed ID: 38656597
[No Abstract] [Full Text] [Related]
13. A Comparative Analysis of Naïve Exosomes and Enhanced Exosomes with a Focus on the Treatment Potential in Ovarian Disorders.
Mousaei Ghasroldasht M; Liakath Ali F; Park HS; Hadizadeh M; Weng SHS; Huff A; Vafaei S; Al-Hendy A
J Pers Med; 2024 Apr; 14(5):. PubMed ID: 38793064
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy.
Ni X; Lu CP; Xu GQ; Ma JJ
Acta Pharmacol Sin; 2024 Apr; ():. PubMed ID: 38622288
[TBL] [Abstract][Full Text] [Related]
15. Comparative clinical significance and biological roles of PFKFB family members in oral squamous cell carcinoma.
Hu KF; Shu CW; Lee CH; Tseng CJ; Chou YH; Liu PF
Cancer Cell Int; 2023 Nov; 23(1):257. PubMed ID: 37919747
[TBL] [Abstract][Full Text] [Related]
16. PFKFB3 Inhibitor 3PO Reduces Cardiac Remodeling after Myocardial Infarction by Regulating the TGF-β1/SMAD2/3 Pathway.
Yang Q; Zong X; Zhuang L; Pan R; Tudi X; Fan Q; Tao R
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509108
[TBL] [Abstract][Full Text] [Related]
17. Role of microRNAs in glycolysis in gynecological tumors (Review).
Chen Q; Shen S; Lv N; Tong J
Int J Oncol; 2023 May; 62(5):. PubMed ID: 37052244
[TBL] [Abstract][Full Text] [Related]
18. Targeting HDAC6 to Overcome Autophagy-Promoted Anti-Cancer Drug Resistance.
Jo H; Shim K; Jeoung D
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076996
[TBL] [Abstract][Full Text] [Related]
19. Targeting of PFKFB3 with miR-206 but not mir-26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulation.
Boscaro C; Baggio C; Carotti M; Sandonà D; Trevisi L; Cignarella A; Bolego C
FASEB J; 2022 Mar; 36(3):e22140. PubMed ID: 35107852
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
